Avelumab Maintenance for Urothelial Carcinoma. Reply. | N Engl J Med;383(25): 2483, 2020 12 17. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Avelumab Maintenance for Urothelial Carcinoma. Reply.

Powles, Thomas; Huang, Bo; di Pietro, Alessandra.

Affiliation

Powles T; St. Bartholomew's Hospital, London, United Kingdom thomas.powles1@nhs.net.
Huang B; Pfizer, Groton, CT.
di Pietro A; Pfizer, Milan, Italy.

N Engl J Med ; 383(25): 2483, 2020 12 17.

Article in En | MEDLINE | ID: mdl-33326729

Subject(s)

Carcinoma, Transitional Cell; Urologic Neoplasms; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Carcinoma, Transitional Cell/drug therapy; Humans; Urologic Neoplasms/drug therapy

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Urologic Neoplasms Limits: Humans Language: En Journal: N Engl J Med Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Urologic Neoplasms Limits: Humans Language: En Journal: N Engl J Med Year: 2020 Document type: Article Affiliation country: United kingdom Country of publication: United States